Device profile of the percept PC deep brain stimulation system for the treatment of Parkinson's disease and related disorders

Introduction: Several software and hardware advances in the field of deep brain stimulation (DBS) have been realized in recent years and devices from three manufacturers are available. The Percept (TM) PC platform (Medtronic, Inc.) enables brain sensing, the latest innovation. Clinicians should be familiar with the differences in devices, and with the latest technologies to deliver optimized patient care. Areas covered: In this device profile, the sensing capabilities of the Percept (TM) PC platform are described, and the system capabilities are differentiated from other available platforms. The development of the preceding Activa (TM) PC+S research platform, an investigational device to simultaneously sense brain signals and provide therapeutic stimulation, is provided to place Percept (TM) PC in the appropriate context. Expert opinion: Percept (TM) PC offers unique sensing and diary functions as a means to refine therapeutic stimulation, track symptoms and correlate them to neurophysiologic characteristics. Additional features enhance the patient experience with DBS, including 3 T magnetic resonance imaging compatibility, wireless telemetry, a smaller and thinner battery profile, and increased battery longevity. Future work will be needed to illustrate the clinical utility and added value of using sensing to optimize DBS therapy. Patients implanted with Percept (TM) PC will have ready access to future technology developments.

Automated summary

Recent advancements in software and hardware in the field of deep brain stimulation (DBS) have led to the development of devices from three manufacturers. The Percept (TM) PC platform offers unique sensing and diary functions for refining therapeutic stimulation and tracking symptoms. Future work is needed to demonstrate the clinical utility and added value of using sensing to optimize DBS therapy.